thiazolidines has been researched along with Cardiometabolic Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Adejumobi, OA; Adeyemi, WJ; Ajibade, TO; David, UE; Fasanmade, AA; Ojetola, AA; Omobowale, TO; Oyagbemi, AA | 1 |
| Koriyama, H; Kurinami, H; Morishita, R; Moritani, T; Nakagami, H; Pang, Z; Shimamura, M; Shimosato, T; Tenma, A | 1 |
| Ichikawa, T; Kohno, S; Nakao, K; Onitsuka, Y; Takeshima, F | 1 |
| Chirayil, MT; Karot, SS; Kishore, A; Mathew, G; Mudgal, J; Nampurath, GK; Nandakumar, K; Surenahalli, VG | 1 |
| Yokoi, H | 1 |
| Hosoda, K | 1 |
| Ogawa, D; Shikata, K | 1 |
3 review(s) available for thiazolidines and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[Thiazolidine].
Topics: Acute Coronary Syndrome; Diabetes Mellitus; Humans; Metabolic Syndrome; Thiazolidines | 2010 |
[Thiazolidine derivatives].
Topics: Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Thiazolidines | 2011 |
[Microinflammation in diabetic nephropathy].
Topics: Animals; Diabetic Nephropathies; Drug Design; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; Molecular Targeted Therapy; PPAR gamma; Rats; Thiazolidines | 2011 |
4 other study(ies) available for thiazolidines and Cardiometabolic Syndrome
| Article | Year |
|---|---|
D-ribose-L-cysteine prevents oxidative stress and cardiometabolic syndrome in high fructose high fat diet fed rats.
Topics: Animals; Blood Pressure; Cysteine; Diet, High-Fat; Fructose; Glucose; Heart Rate; Lipid Metabolism; Male; Metabolic Syndrome; Oxidative Stress; Rats; Rats, Wistar; Thiazolidines; Xanthine Oxidase | 2021 |
The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome.
Topics: Aging; Animals; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Endothelium, Vascular; Glucose; Insulin Resistance; Metabolic Syndrome; Pyrazoles; Rats; Rats, Inbred SHR; Thiazolidines | 2014 |
Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
Topics: Aged; Biguanides; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Western; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intra-Abdominal Fat; Japan; Logistic Models; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Thiazolidines; Ultrasonography; Waist Circumference | 2014 |
Dose-related antihyperglycemic and hypolipidemic effects of two novel thiazolidin-4-ones in a rodent model of metabolic syndrome.
Topics: Animals; Animals, Newborn; Blood Glucose; Cell Line; Cholesterol; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Hypolipidemic Agents; Interleukin-6; Liver; Macrophages; Male; Metabolic Syndrome; Molecular Structure; Nitric Oxide; Prediabetic State; Rats, Wistar; Reactive Oxygen Species; Sodium Glutamate; Thiazolidines; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |